Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the
past decades, and are now the most common type of small bowel tumor. Consequently …

There have been significant developments in diagnostic and therapeutic options for patients
with neuroendocrine tumors (NETs). Key phase 3 studies include the CLARINET trial, which …

M. Pavel a D. O'Toole b F. Costa c J. Capdevila d D. Gross e R. Kianmanesh f E. Krenning g
U. Knigge h R. Salazar i U.-F. Pape a K. Öberg j all other Vienna Consensus Conference …

Neuroendocrine neoplasms constitute a diverse group of tumors that derive from the
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …

Abstract In 2010, the World Health Organization (WHO) classification of neuroendocrine
neoplasms was reviewed and validated the crucial role of the proliferative rate. According to …

Objectives Liver metastasis from a neuroendocrine tumour (NET) represents a significant
clinical entity. A multidisciplinary group of experts was convened to develop state-of-the-art …

Patients who have neuroendocrine tumors frequently present with liver metastases. A wide
panel of treatment options exists for these patients. Liver resection with curative intent …

Neuroendocrine tumors from gastro-pancreatic origin (GEP-NET) can be responsible for
liver metastases. Such metastases can be the dominant part of the disease as well due to …

Pancreatic neuroendocrine tumors (PNETs) are rare and represent a heterogeneous
disease. PNET can be functioning or non-functioning with different clinical presentations and …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …